J&J May Have Violated Foreign Corrupt Practices Act

Law360, New York (February 13, 2007, 12:00 AM EST) -- Johnson & Johnson has told the U.S. Department of Justice and the U.S. Securities and Exchange Commission that it may have broken the Foreign Corrupt Practices Act, which prohibits U.S.-based companies from paying foreign officials to influence business deals.

The health care company said Monday that Michael J. Dormer, worldwide chairman of medical devices and diagnostics, had retired because he had “ultimate responsibility by virtue of [his] position.”

The company said that it believed its subsidiaries outside the U.S. had made improper payments in connection with...
To view the full article, register now.